What is lymphangiomatosis?
Lympangiomatosis (lymph) is a disease of the lymphatic system. It can affect all areas of the body except the central nervous system or brain. This disease is a rare type of neoplasm and tends to be widespread than located in one area. It is commonly confused with lympangioleiomyomatosis, which is caused by abnormal growth of smooth muscles.
Lymph nodes are associated with blood vessels in each area of the body except the central nervous system and brain. The lymphatic system is responsible for distributing body fluids other than blood throughout the body. Lymphatic disease or other abnormalities can lead to lesions or lympangiomas, which are neoplasms of growth.
Research shows that lympangiomatosis may be congenital or lead to real newborns. Congenital types are caused by abnormalities occurring in the lymphatic system from birth. Real neoplasms are a new tumor growth. The exact cause of this category of rare diseases is not clear.
Most Lympang casesIOMATOZYSIZE DISCOUNT LYMFANGIOMES. These neoplasms can be distributed in completely different areas, causing compression, obstacles or structural damage because they block lymphatic blood vessels. They can also consist of multiple growths that occur in one or more organs. When growth in organs occurs, organs may damage and may also lead to further damage due to incorrect organ function. For example, lung growth can cause oxygen deprivation, which is harmful to other vital organs such as heart and brain.
Several factors determine the type of treatment of lympangiomatosis received by the patient. Not every method of treatment will be effective for every patient. It is not uncommon for patients to undergo several types of treatment procedures before it is found. Vascular growth inhibitors may slow progression for some patients. Chemotherapy Jetaké successful in slowing growth.
The patient's age and the severity of the disease affect the prognosis of lympangiomatosis. In general, finding effective treatment can rapidly increase the patient survival. Although most growths are benign, they may pose dangerous risks depending on their location. Whenever possible, surgical removal of growth can also increase survival. Aggressive growth must be treated aggressively.
Lympangiomatosis has a complication similar to many other diseases related to the neoplasm. Regardless of its origin, traditional treatment is not always effective. Doctors must carefully monitor growth to find out which modality works. Younger children have a better chance of successful treatment if growth is not located in vital organs.